Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.

Health Care

Life Sciences

Therapeutics

Beacon Therapeutics

Beacon Therapeutics' headquarters in Alachua, FL, United States

David Fellows

Nadia Waheed

Martin Quinn

Xuandai Nguyen

Daniel C. Chung

Benjamin G.

Bryce Lay

Mark Murphy Fca

Donna Burch

Petra Marks

Amy Adelman House

Ben Rigby

Duncan Whitaker

Abraham Scaria

The Leadership Team at Beacon Therapeutics drives the strategic vision and operational efficiency of the company, ensuring alignment across all departments in the pursuit of developing innovative gene therapies for retinal diseases. This team is responsible for overseeing clinical development, regulatory compliance, financial management, and intellectual property, while fostering collaboration among scientific, medical, and operational leaders to advance the company’s mission of restoring sight and enhancing quality of life for patients.

Leadership Team

The Clinical Research and Operations team at Beacon Therapeutics is responsible for managing and executing clinical trials focused on innovative gene therapies for retinal diseases. This team ensures compliance with regulatory requirements, oversees patient recruitment and enrollment, and collaborates with medical and operational staff to streamline clinical processes. Their goal is to advance research initiatives that restore vision and improve patient outcomes in ophthalmic conditions.

Clinical Research and Operations

The Research and Development team at Beacon Therapeutics is dedicated to advancing innovative gene therapies aimed at treating rare retinal diseases. This team, comprised of scientists and medical affairs experts, conducts cutting-edge research, develops experimental therapies, and performs rigorous clinical evaluations to ensure safety and efficacy. Their collaborative efforts are crucial to the company's mission of restoring and improving vision for individuals affected by these debilitating conditions.

Research and Development

This department provides strategic direction and governance for the organization.

Executive Leadership

The Finance and Operations team at Beacon Therapeutics is responsible for managing financial analysis, budgeting, and forecasting to ensure the company's financial health. They also oversee strategic sourcing and supply chain logistics, facilitating efficient procurement and operational processes that support the development and delivery of innovative gene therapies for retinal diseases. This team plays a crucial role in aligning financial objectives with operational initiatives to drive the company's mission to restore vision.

Finance and Operations

The Clinical Development Team at Beacon Therapeutics is responsible for designing, implementing, and managing clinical trials for innovative gene therapies aimed at treating rare retinal diseases. This team collaborates closely with regulatory agencies, research institutions, and internal stakeholders to ensure the safety and efficacy of novel therapies, ultimately working to restore vision for patients affected by blindness. Their expertise spans clinical operations, strategic planning, and gene therapy research to advance the company's therapeutic pipeline.

Beacon Therapeutics

Org chart

Teams

Leadership Team

Clinical Research and Operations

Research and Development

Executive Leadership

Finance and Operations

Clinical Development Team

Offices

Beacon Therapeutics

Org chart

Teams

Leadership Team

Clinical Research and Operations

Research and Development

Executive Leadership

Finance and Operations

Clinical Development Team

Offices

Related companies